155 related articles for article (PubMed ID: 1714885)
21. Oral flecainide acetate for the treatment of ventricular arrhythmias.
Anderson JL; Stewart JR; Perry BA; Van Hamersveld DD; Johnson TA; Conard GJ; Chang SF; Kvam DC; Pitt B
N Engl J Med; 1981 Aug; 305(9):473-7. PubMed ID: 7019711
[TBL] [Abstract][Full Text] [Related]
22. Mexiletine, a new antiarrhythmic agent, for treatment of premature ventricular complexes.
Mehta J; Conti CR
Am J Cardiol; 1982 Feb; 49(2):455-60. PubMed ID: 6174042
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of disopyramide and mexiletine used alone and in combination for ventricular arrhythmias in patients with and without overt heart disease.
Tanabe T; Takahashi K; Yoshioka K; Goto Y
Int J Cardiol; 1991 Sep; 32(3):303-12. PubMed ID: 1724233
[TBL] [Abstract][Full Text] [Related]
24. Mexiletine for the treatment of ventricular arrhythmias associated with chronic obstructive pulmonary disease.
Fracalossi C; Ziacchi V; Farisè F; Rossi A; Marino A; Lomanto B; Moretti L
G Ital Cardiol; 1989 Jan; 19(1):46-52. PubMed ID: 2744314
[TBL] [Abstract][Full Text] [Related]
25. [Evaluation of flecainide in the therapy of chronic ventricular arrhythmia using the acute oral load method].
Schwartz PJ; Facchini M; Bonazzi O; Cuspidi C; Priori S; Varisco T; Zuanetti G
G Ital Cardiol; 1985 Mar; 15(3):273-82. PubMed ID: 4018465
[TBL] [Abstract][Full Text] [Related]
26. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A
G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
[TBL] [Abstract][Full Text] [Related]
27. Mexiletine: long-term efficacy and hemodynamic actions in patients with ventricular arrhythmia.
Sami M; Lisbona R
Can J Cardiol; 1985; 1(4):251-8. PubMed ID: 2413974
[TBL] [Abstract][Full Text] [Related]
28. Tocainide and metoprolol: an efficacious therapeutic combination in the treatment of premature ventricular beats.
Capucci A; Frabetti L; Gubelli S; Boriani G; Marchesini B; Boschi S; Ambrosioni E; Magnani B
Clin Cardiol; 1989 Jun; 12(6):322-31. PubMed ID: 2472242
[TBL] [Abstract][Full Text] [Related]
29. [Potentiation of an anti-arrhythmia action by the combined use of mexiletine and propranolol].
Pacholke H; Beck OA; Hochrein H
Dtsch Med Wochenschr; 1984 Mar; 109(9):330-4. PubMed ID: 6199177
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of mexiletine in chronic ventricular arrhythmias compared with quinidine: a single-blind, randomized trial.
Singh JB; Rasul AM; Shah A; Adams E; Flessas A; Kocot SL
Am J Cardiol; 1984 Jan; 53(1):84-7. PubMed ID: 6362388
[TBL] [Abstract][Full Text] [Related]
31. Combination of flecainide and mexiletine for the treatment of ventricular tachyarrhythmias.
Jordaens LJ; Tavernier R; Vanmeerhaeghe X; Robbens E; Clement DL
Pacing Clin Electrophysiol; 1990 Sep; 13(9):1127-35. PubMed ID: 1700388
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the efficacy of flecainide acetate in the treatment of ventricular premature contractions.
Muhiddin KA; Turner P; Hellestrand K; Camm AJ
Postgrad Med J; 1985 Jun; 61(716):489-96. PubMed ID: 2409543
[TBL] [Abstract][Full Text] [Related]
33. Antiarrhythmic efficacy of penticainide and comparison with disopyramide, flecainide, propafenone and mexiletine by acute oral drug testing.
Priori SG; Bonazzi O; Facchini M; Varisco T; Schwartz PJ
Am J Cardiol; 1987 Nov; 60(13):1068-72. PubMed ID: 3118693
[TBL] [Abstract][Full Text] [Related]
34. Comparative study of mexiletine and quinidine in the treatment of ventricular ectopia.
Assey ME; Hudson WM; Hanger KH; Miller SC
South Med J; 1985 May; 78(5):565-8. PubMed ID: 2581322
[TBL] [Abstract][Full Text] [Related]
35. [Treatment of ventricular extrasystole with mexiletine and Neo-gilurytmal in myocardial infarct patients].
Loskot F; Bauer U
Adv Clin Pharmacol; 1978; 16():75-80. PubMed ID: 80103
[No Abstract] [Full Text] [Related]
36. [Anti-arrhythmia action of mexiletine (KO 1173) on ventricular ectopic arrhythmias in dependence of its serum concentration].
Merx W; Henning B; Brunner H; De Bakker JM; Härtel H
Verh Dtsch Ges Kreislaufforsch; 1977; 43():427-8. PubMed ID: 77598
[No Abstract] [Full Text] [Related]
37. [Comparison of the efficacy of moricizine and disopyramide in the treatment of ventricular extrasystoles].
Fauchier JP; Babuty D; Rouesnel P; Cosnay P; Estepo J
Arch Mal Coeur Vaiss; 1991 Apr; 84(4):553-60. PubMed ID: 1712193
[TBL] [Abstract][Full Text] [Related]
38. [Evaluation of delayed-action preparations of mexiletine and dihydroquinidine in the treatment of ventricular extrasystolic arrhythmia].
Accettura D; De Toma L; Mangini SG; Lagioia R; Scrutinio D; Mastropasqua F; Caiati C; Rizzon P
Cardiologia; 1987 Sep; 32(9):999-1003. PubMed ID: 2446764
[No Abstract] [Full Text] [Related]
39. Effects of mexiletine, propafenone and flecainide on signal-averaged electrocardiogram.
Lombardi F; Finocchiaro ML; Dalla Vecchia L; Rech R; Castelli A; Pastine J; Cappiello E
Eur Heart J; 1992 Apr; 13(4):517-25. PubMed ID: 1600992
[TBL] [Abstract][Full Text] [Related]
40. International mexiletine and placebo antiarrhythmic coronary trial: I. Report on arrhythmia and other findings. Impact Research Group.
J Am Coll Cardiol; 1984 Dec; 4(6):1148-63. PubMed ID: 6209318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
